Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
2.
Cancer Epidemiol Biomarkers Prev ; 17(11): 3020-5, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18990744

ABSTRACT

BACKGROUND: Experimental studies indicate the chemopreventive properties of green tea extract (GTE) on colorectal cancer. Epidemiologically, green tea consumption of > 10 cups daily reduced colorectal cancer risk in Japanese. Because colorectal adenomas are the precursors to most sporadic colorectal cancers, we conducted a randomized trial to determine the preventive effect of GTE supplements on metachronous colorectal adenomas by raising green tea consumption in the target population from an average of 6 cups (1.5 g GTE) daily to > or = 10 cups equivalent (2.5 g GTE) by supplemental GTE tablets. METHODS: We recruited 136 patients, removed their colorectal adenomas by endoscopic polypectomy, and 1 year later confirmed the clean colon (i.e., no polyp) at the second colonoscopy. The patients were then randomized into two groups while maintaining their lifestyle on green tea drinking: 71 patients supplemented with 1.5 g GTE per day for 12 months and 65 control patients without supplementation. Follow-up colonoscopy was conducted 12 months later in 125 patients (65 in the control group and 60 in the GTE group). RESULTS: The incidence of metachronous adenomas at the end-point colonoscopy was 31% (20 of 65) in the control group and 15% (9 of 60) in the GTE group (relative risk, 0.49; 95% confidence interval, 0.24-0.99; P < 0.05). The size of relapsed adenomas was also smaller in the GTE group than in the control group (P < 0.001). No serious adverse events occurred in the GTE group. CONCLUSION: GTE is an effective supplement for the chemoprevention of metachronous colorectal adenomas.


Subject(s)
Adenoma/prevention & control , Colorectal Neoplasms/prevention & control , Neoplasms, Second Primary/prevention & control , Plant Extracts , Tea , Adult , Aged , Colonoscopy , Female , Humans , Incidence , Japan , Male , Middle Aged , Pilot Projects , Treatment Outcome
3.
J Gastroenterol ; 37(10): 844-8, 2002.
Article in English | MEDLINE | ID: mdl-12424569

ABSTRACT

A 64-year-old woman with severe intestinal Behçet's disease who was unresponsive to conventional therapies, including intensive intravenous steroid injections, underwent intraarterial steroid injection therapy. After the infusion of prednisolone into the mesenteric arteries, her colon ulcers improved markedly, and the frequency of bloody stools decreased immediately. The present case suggests that intraarterial steroid injection therapy may be potentially useful in severe intestinal Behçet's disease.


Subject(s)
Anti-Inflammatory Agents/administration & dosage , Behcet Syndrome/drug therapy , Glucocorticoids/administration & dosage , Intestinal Diseases/drug therapy , Prednisolone/administration & dosage , Female , Humans , Injections, Intra-Arterial , Mesenteric Arteries , Middle Aged
4.
J Cancer Res Clin Oncol ; 128(10): 569-74, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12384801

ABSTRACT

PURPOSE: We analyzed the possible risk factors for metachronous colon tumors after endoscopic resection of initial tumors. METHODS: Three hundred and twenty-one patients entered the surveillance study after colonoscopic resection of initial tumors between 1985 and 1999. Histology of initial tumors was adenoma in 214 patients and carcinoma in 107 patients. Solitary tumor was observed in 196 patients and multiple tumors in 125 at initial endoscopy. The median surveillance period was 39 (range, 12-112) months, and the median frequency of surveillance colonoscopy was three (range, 2-10) times. RESULTS: Metachronous neoplasms were identified in 114 of 321 surveillance cases (36%). In the 114 cases, the number of patients with metachronous adenoma was 103 (90%) and that of carcinoma was 11 (10%). Clinical characteristics at entry - including age, gender, multiplicity of polyp, histology of polyp, and site of polyp - were not different between patients with metachronous tumors and those without metachronous tumors. Kaplan-Meier analysis revealed that patients with a histology of carcinoma and those with multiple polyps at entry developed metachronous tumors significantly earlier than did patients with initial adenomas and initial solitary polyp, respectively ( P<0.001, P<0.001). However, other characteristics at entry did not produce significant differences in the rate of the development of metachronous tumors using Kaplan-Meier analysis. Proportional hazards model analysis revealed that histology of the initial tumor as carcinoma (relative risk, 1.690, 95% confidence interval, 1.118-2.555) and multiplicity (1.472, 1011-2.143) were significant risk factors for metachronous colon tumors. The 75%, 50%, and 25% metachronous tumor-free periods after initial polypectomy were 14, 21, and 39 months, respectively. CONCLUSIONS: These results may help optimizing surveillance strategies for metachronous colon tumors and raising the economic benefit of colonoscopy.


Subject(s)
Adenocarcinoma/pathology , Adenoma/pathology , Colonic Neoplasms/pathology , Colonic Polyps/surgery , Neoplasms, Second Primary/pathology , Adenocarcinoma/etiology , Adenoma/etiology , Adult , Aged , Aged, 80 and over , Colonic Neoplasms/etiology , Colonic Polyps/pathology , Colonoscopy , Female , Humans , Male , Middle Aged , Neoplasms, Second Primary/etiology , Population Surveillance , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...